icon

Veterinary CE Courses
by Myos Animal Health

Myos Animal Health provides free online veterinary CE courses for vet techs, nurses, veterinarians and those in the animal muscle health industry.

Since 2000, we have issued over 2,000 RACE CE certificates to animal muscle health professionals representing 50 nations. Myos provides 5 CE courses RACE approved by the AAVSB.

Our CE Courses

  • Small Animal Sarcopenia: A Neglected Syndrome of Importance to Cats and Dogs
  • The Veterinarian's Guide to Antioxidants for Dogs
  • The Nutritional Management of Canine Osteoarthritis
  • The Multimodal Management of Canine Osteoarthritis

Recent Advances in Understanding the Biology of Osteoarthritis: Applications in Canine and Equine Medicine

CE Course:

The course, Recent Advances in Understanding the Biology of Osteoarthritis: Applications in Canine and Equine Medicine is accredited by the American Association of Veterinary State Boards (AAVSB) for inclusion in their Registry of Approved Continuing Education (RACE) programs (RACE Program Number # 20-913835).

Veterinarians and Veterinary Technicians will receive credit for 1.00 hours of CE upon successful completion of this course.

Course Outline:

There will be a detailed discussion in this CE Course on the role that ribosome aberrations play in osteoarthritis. Specifically, the instructor will highlight ribosome aberrations that have been found from early-stage ribosome biogenesis, through ribosome build-up and maturation, up to preferential translation. The molecular mechanisms that account for cartilage degeneration and regeneration will be discussed with an emphasis on new findings from single-cell RNA sequencing (scRNA-seq). After a brief review of major non-coding classes of RNA, the role of microRNAs and small non-coding RNAs will be discussed as molecular signatures for osteoarthritis. The role of microRNAs as therapeutics will be discussed with a detailed example of microRNA29a treatment for tendon injury in horses. New findings that highlight the role that cartilage ribosomal RNA (rRNA) post-translational modifications (PTMs) play in the pathogenesis of osteoarthritis will be explained. Recent findings elucidating the role that the gut microbiome, a regulator of inflammation, plays in osteoarthritis, a disease with a major inflammatory component will be covered.

The last third of the CE Course will highlight the potential of novel therapies to address osteoarthritis in dogs and horses such as stem cells, microRNAs, and myostatin inhibitors. Mesenchymal stem cells (MSCs) offer promise due to their multipotency for differentiation into chondrocytes and their ability to modulate the immune system. Extracellular vesicles (EVs) may be able to heal and prevent tissue damage in osteoarthritis. A study that evaluated purified MSC-derived EVs in horses with osteoarthritis will be covered. Muscle wasting plays an important role in joint destabilization in canine and equine osteoarthritis. Exercise, microRNAs, gene therapy, and myostatin inhibitors can address muscle wasting in osteoarthritis.  

Tuesday, September 13, 2022 @ 4 pm (EST - USA/Canada):

Recent Advances in Understanding the Biology of Osteoarthritis: Applications in Canine and Equine Medicine

Thursday, September 15, 2022 @ 12 pm (EST - USA/Canada):

Recent Advances in Understanding the Biology of Osteoarthritis: Applications in Canine and Equine Medicine

Small Animal Sarcopenia: A Neglected Syndrome of Importance to Cats and Dogs

CE Course:

The course, Small Animal Sarcopenia: A Neglected Syndrome of Importance to Cats and Dogs is accredited by the American Association of Veterinary State Boards (AAVSB) for inclusion in their Registry of Approved Continuing Education (RACE) programs (RACE Program Number # 1589-42207).

Veterinarians and Veterinary Technicians will receive credit for 1.00 hours of CE upon successful completion of this course.

Course Outline:

  • Muscle Health & Longevity – Human & Small Animal Clinical Studies
  • Diagnosis of Canine Sarcopenia
  • Muscle Condition Score
  • 6 Minute Walk Test
  • Canine Manual Muscle Testing
  • CT Imaging
  • Muscle Mass Changes over Lifespan of Cats and Dogs
  • Impact of Muscle Mass on Chronic Heart Failure Survival in Dogs
  • Frailty Related Phenotype
  • Impact of Muscle Mass on Chronic Kidney Disease Survival in Cats
  • Pharmaceutical Clinical Trials to Address Muscle Wasting in Dogs and Catso Myostatin Inhibitiono Capromorelin (Canine & Feline Clinical Studies)
  • Nutrition Clinical Trials to Address Muscle Wasting in Dogs and Catso Omega-3 Fatty Acidso Krillo Fortetropin®

Registration:

There is no fee to register. The lecture will be delivered via the Zoom Platform. To register, go to the links below:

  • Check back soon
  • Check back soon

The Multimodal Management of Canine Osteoarthritis

CE Course:

The course, The Multimodal Management of Canine Osteoarthritis is accredited by the American Association of Veterinary State Boards (AAVSB) for inclusion in their Registry of Approved Continuing Education (RACE) programs (RACE Program Number #20-912483).

Veterinarians and Veterinary Technicians will receive credit for 1.00 hours of CE upon successful completion of this course.

Course Outline:

Multimodal management of canine osteoarthritis is the foundation for medically treating arthritic dogs. The tenets of multimodal management that will be covered include:

Anti-inflammatory Medications
COX-2 Drugs, PGE2 Inhibitors, EP4 Antagonists
Chondroprotective Supplements
Glucosamine HCl, Chondroitin Sulfate, Methylsulfonylmethane (MSM), Eggshell Membrane, Polysulfated Glycosaminoglycans (PSAGs), Hyaluronic Acid
Weight Management
14-Year Life Span Study in Dogs
Controlled exercise
Swimming, Stairs/Hill Climbing Exercises, Walking an Osteoarthritic Dogs
Essential Fatty Acids
Omega-3 Fatty Acids (EPA, DHA)
Adjunctive Therapies
Herbal Therapies (Cannabidiol, Boswellia, Turmeric, Avocado/Soybean Unsaponifiables, Phycocyanin)
Regenerative Therapies (Stem Cells, Platelet-Rich Plasma)
Rehabilitation Therapies (Laser, E-stim, Ultrasound, Underwater Treadmill, Massage)
Next Generation Therapies (Radiosynoviorthesis)

One area that has largely been ignored in with regards to the management of canine osteoarthritis is muscle atrophy. Addressing muscle atrophy through the use of pro-myogenic nutritional supplements (i.e. Fortetropin) will also be discussed.

Tuesday June 7, 2022 @ 8 pm (EST)

The Multimodal Management of Canine Osteoarthritis with Professor Michael Jaffe

Thursday, June 9, 2022 @ 12 pm (EST)

The Multimodal Management of Canine Osteoarthritis with Professor Michael Jaffe

The Veterinarian's Guide to Antioxidants for Dogs

CE Course:

The course, The Veterinarian's Guide to Antioxidants for Dogs is accredited by the American Association of Veterinary State Boards (AAVSB) for inclusion in their Registry of Approved Continuing Education (RACE) programs.

Veterinarians and Veterinary Technicians will receive credit for 1.00 hours of CE upon successful completion of this course.

Course Outline:

The first 15% of the course will discuss the formation of Reactive Oxygen Species (ROS) (i.e. Superoxide Anion, Hydrogen Peroxide), sources of oxidants (i.e. heavy metals, UV), the molecular impact of ROS (i.e. protein misfolding, DNA damage, lipid peroxidation), enzymatic scavengers of ROS and an overview of the clinical impact of oxidative stress with two detailed examples that cover cancer and type 2 diabetes.

The remaining 85% of the course will discuss examples of veterinary clinical trials involving antioxidants. Some of the antioxidants that will be discussed will include (1) Anthocyanins (2) Astaxanthin (3) Lutein (4) Zeaxanthin (5) Melatonin (6) Resveratrol (7) Vitamin E (8) Alpa-Lipoic Acid and (9) Beta-Carotene.

The specific clinical studies discussed will relate to the application of antioxidants on (1) canine innate immunity (polymorphonuclear leucocyte phagocytosis) (2) reactive oxygen metabolites (3) DNA damage (4) canine cognition (5) obesity-related oxidative stress (6) mitochondrial dysfunction (7) tooth removal oxidative stress (8) canine vision (retinal function and refractive error) and (9) muscle atrophy following TPLO surgery.

Registration:

There is no fee to register. The lecture will be delivered via the Zoom Platform. To register, go to the links below:

  • CHECK BACK SOON
  • CHECK BACK SOON

Your Instructor

Mandy Peffers, BVetMed, PhD, FRCVS
Professor, Department of Musculoskeletal Science and Ageing, Institute of Life Course & Medical Sciences
Wellcome Trust Clinical Intermediate Fellow
University of Liverpool School of Veterinary Science, United Kingdom

After a degree in Animal Science at the University of Leeds, Professor Peffers undertook her veterinary degree at The Royal Veterinary College, University of London and qualified as a veterinarian in 1995. Professor Peffers then spent 11 years in industry and private practice before going back to do a PhD supported by the Wellcome Trust. Professor Peffers first undertook a one-year Wellcome Trust Veterinary Research Entry Fellowship before becoming an Wellcome Trust Integrated Veterinary Training Fellow. The first three years of funding were for a PhD entitled “Proteomic and transcriptomic signatures of cartilage ageing and disease.” The next three years of the fellowship were in a post-doctoral role in which she studied a ‘A Systems Biology Approach to Musculoskeletal Ageing’. 


Professor Peffers is currently a Wellcome Trust Clinical Intermediate Fellow studying ‘The role of small nucleolar RNAs in cartilage ageing and disease’. Her research group studies the epigenetics of musculoskeletal aging and disease in man, dogs and horses. The 'Peffers Lab' consists currently of four PhD students, two post doctoral research associates and a masters student.

Recent Publications

  • van den Akker, Guus GH, et al. "Ribosome dysfunction in osteoarthritis." Current opinion in rheumatology 34.1 (2022): 61-67.
  • Ali, Shabana A., et al. "The non-coding RNA interactome in joint health and disease." Nature Reviews Rheumatology 17.11 (2021): 692-705.
  • Anderson, James R., et al. "Optimization of synovial fluid collection and processing for NMR metabolomics and LC-MS/MS proteomics." Journal of proteome research 19.7 (2020): 2585-2597.
  • Peffers, Mandy J., et al. "SnoRNA signatures in cartilage ageing and osteoarthritis." Scientific reports 10.1 (2020): 1-10.

Your Instructor

An international authority in canine osteoarthritis, Professor Michael Jaffe currently serves as the Service Chief of Small Animal Surgery at Mississippi State University College of Veterinary Medicine. Since 2015, Professor Jaffe has served as Associate Editor, Frontiers in Veterinary Science, Veterinary Surgery and Anesthesiology Section. 


Professor Jaffe is passionate about Veterinary Education and has been actively involved in training Veterinary Students, Veterinary Residents and CCRP Professionals. Professor Jaffe has published peer reviewed papers in areas that span canine sports medicine and rehabilitation, canine osteoarthritis, photothermal nanocomposites, laparoscopic surgery, and the management of muscle injuries. 


Professor Jaffe graduated with a DVM from the University of Missouri, Columbia and completed his internship and residency training in Companion Animal Surgery at Louisiana State University.

Learn more about Dr. Michael Jaffe

Selected Publications:

Michael Jaffe, David Levine, Denis J. Marcellin-Little, Henry Steven Adair, Andris J. Kaneps Topic Editor: Veterinary Sports Medicine and Physical Rehabilitation ebook. Frontiers, 2020


David Levine, Henry Steven Adair, Denis J. Marcellin-Little, Michael Jaffe and Andris J. Kaneps. Editorial: Veterinary Sports Medicine and Physical Rehabilitation. Front. Vet. Sci., 28 April 2020


Madaline Mushaben, Russell Urie, Tanner Flake, Michael Jaffe, Kaushal Rege and Jeffrey Heys: Spatiotemporal Modeling of Laser Tissue Soldering Using Photothermal Nanocomposites. Lasers in Surgery and Medicine, Oct. 2017.

Your Instructor

Dr. Padliya has served as Vice President, R&D at MYOS Corporation since 2013 during which time he has managed human and veterinary clinical programs in addition to preclinical studies with leading universities and CROs to study the impact of nutrition products on sarcopenia, muscle disuse atrophy and cancer cachexia in humans and animals.


He provides scientific oversight to MYOS' Animal Health Business, working closely with leading Veterinarians and Veterinary Researchers across the United States to leverage the extensive research behind the advanced nutrition product, Fortetropin®.


The AAVSB RACE-Approved Veterinary Continuing Education (CE) Courses that Dr. Padliya has developed and taught have been completed by Veterinarians that hail from 44 nations including the United States, Canada, United Kingdom, France, Germany, Switzerland, Belgium, Finland, Israel, South Korea, Australia and Brazil and that represent leading Colleges of Veterinary Medicine in addition to some of the world’s largest Pet Food and Animal Health Companies.


Since Dr. Padliya launched MYOS’ CE Program in June 2020, 1400 RACE Certificates of Completion have been issued.